Neocardiab care
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glimefine MV 1mg/500mg/0.2mg Tablet is a combination of medicines used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet
Glimefine MV 1mg/500mg/0.2mg Tablet belongs to a category of medicines known as anti-diabetic drugs. It is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glimefine MV 1mg/500mg/0.2mg Tablet is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Glimefine MV 1mg/500mg/0.2mg Tablet.
Glimefine MV 1mg/500mg/0.2mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Glimefine MV 1mg/500mg/0.2mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Glimefine MV 1mg/500mg/0.2mg Tablet is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines alcohol or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain loss of appetite or yellowing of the eyes or skin (jaundice).
Glimefine MV 1mg/500mg/0.2mg Tablet is a combination of three medicines: Glimepiride, Metformin and Voglibose. This medication is used in the treatment of type 2 diabetes mellitus (DM). It improves blood glucose levels in adults when taken along with proper diet and regular exercise.
Side effects may occur during use of Glimefine MV 1mg/500mg/0.2mg Tablet, including hypoglycemia (low blood sugar level), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash and respiratory tract infection.
Use of Glimefine MV 1mg/500mg/0.2mg Tablet should be avoided if you have known allergies to any of the components or excipients of this medication, or if you suffer from moderate to severe kidney disease or inflammatory bowel disease, colonic ulcerations and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Glimefine MV 1mg/500mg/0.2mg Tablet with alcohol is not advisable as it may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, Glimefine MV 1mg/500mg/0.2mg Tablet can cause hypoglycemia (low blood sugar level). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feelings of anxiety or shakiness. This is more likely when missing meals, consuming alcohol, overexerting, taking other antidiabetic medication simultaneously, or delaying food intake.
Store this medicine in its original container, tightly closed. Refer to the instructions provided on the packaging label or medication pack. Dispose of unused medication according to local regulations and ensure it is not accessible by children, pets, or others.